Ovarian reserve markers and assisted reproductive technique (ART) outcomes in women with advanced endometriosis

Reproductive Biology and Endocrinology

Namir G Al-Tawil³  Talha Al-Shawaf²  Shahla K Alalaf¹  Safiya A Wahd¹ 

[1] Department of Obstetrics and Gynecology, College of Medicine, Hawler Medical University, Erbil, Iraq;Department of Primary Care and Public Health, Imperial College, London, UK;Department of Community Medicine, College of Medicine, Hawler Medical University, Erbil, Iraq

关键词: Live birth rate;    Intracytoplasmic sperm injection (ICSI);    Mature oocyte;    Antral follicle count (AFC);    Stage III-IV endometriosis;   

Others  :  1132324
DOI  :  10.1186/1477-7827-12-120

 received in 2014-09-25, accepted in 2014-11-26,  发布年份 2014

【 摘 要 】

Background

The role of ovarian reserve markers as predictors of the controlled ovarian stimulation (COS) response in intracytoplasmic sperm injection (ICSI) cycles in women with endometriosis has been much debated. The aim of the present study is to assess the predictability of ovarian reserve markers for the number of mature oocytes (MII) retrieved and to assess the pregnancy rate and live birth rate in women with advanced endometriosis.

Methods

Two hundred eighty-five infertile women who had laparoscopy followed by a first ICSI cycle were recruited in this prospective study. One hundred ten patients were diagnosed with endometriosis stage III-IV (group 1), and 175 patients had no endometriosis (group II). Sixty-three patients in group 1 had no history of previous endometrioma surgery (group Ia), and 47 patients had a history of previous endometrioma surgery (group Ib).

Results

The number of mature oocytes retrieved was significantly lower in women with advanced endometriosis than in women with no endometriosis. The number of mature oocytes retrieved in women with and without endometriosis was best predicted by antral follicle count (AFC) and age, whereas only AFC was a predictor in women with previous endometrioma surgery (odds ratio: 0.49; 95% confidence interval: 0.13-0.60). Women with endometriosis had a lower rate of live births than the control group, but this difference was not statistically significant; the number of live births was significantly lower in those with previous endometrioma surgery.

Conclusions

The best predictor of the COS response in ICSI was AFC, followed by age. Women receiving ICSI following surgery for ovarian endometrioma had a poorer clinical outcome and lower rate of live births compared with those with endometriosis but no previous surgery and the control group.

【 授权许可】

   
2014 Wahd et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

【 参考文献 】

• [1]Giudice LC, Kao LCP: Endometriosis. Lancet 2004, 364:1789-1799.
• [2]Giudice LC: Clinical practice. Endometriosis. N Engl J Med 2010, 362:2389-2398.
• [3]Ozkan S, Murk W, Arici A: Endometriosis and infertility: epidemiology and evidence-based treatments. Ann N Y Acad Sci 2008, 1127:92-100.
• [4]Bulletti C, Coccia ME, Battistoni S, Borini A: Endometriosis and infertility. Assist Reprod Genet 2010, 27:441-447.
• [5]Yoo JH, Cha SH, Park CW, Kim JY, Yang KM, Song IO, Koong MK, Kang IS, Kim HO, Kim HO: Serum anti-Müllerian hormone is a better predictor of ovarian response than FSH and age in IVF patients with endometriosis. Clin Exp Reprod Med 2011, 38(4):222-227. doi:10.5653/cerm.2011.38.4.222. Epub 2011 Dec 31
• [6]Park CW, Song IO, Koong MK: IVF/ICSI outcomes of women with minimal to mild endometriosis associated infertility and unexplained infertility. Korean J Obstet Gynecol 2007, 50:322-328.
• [7]Hock DL, Sharafi K, Dagostino L, Kemmann E, Seifer DB: Contribution of diminished ovarian reserve to hypofertility associated with endometriosis. J Reprod Med 2001, 46:7-10.
• [8]Barnhart K, Dunsmoor-Su R, Coutifaris C: Effect of endometriosis on in vitro fertilization. Fertil Steril 2002, 77:1148-1155.
• [9]Iwase A, Hirokawa W, Goto M, Takikawa S, Nagatomo Y, Nakahara T, Manabe S, Kikkawa F: Serum anti-Mullerian hormone level is a useful marker for evaluating the impact of laparoscopic cystectomy on ovarian reserve. Fertil Steril 2010, 94:2846-2849.
• [10]Hirokawa W, Iwase A, Goto M, Takikawa S, Nagatomo Y, Nakahara T, Bayasula B, Nakamura T, Manabe S, Kikkawa F: The post-operative decline in serum anti-Mullerian hormone correlates with the bilaterality and severity of endometriosis. Hum Reprod 2011, 26:904-910.
• [11]Shebl O, Ebner T, Sommergruber M, Sir A, Tews G: Anti Muellerian hormone serum levels in women with endometriosis: a case–control study. Gynecol Endocrinol 2009, 25:713-716.
• [12]Esinler I, Bozdag G, Aybar F, Bayar U, Yarali H: Outcome of in vitro fertilization/intracytoplasmic sperm injection after laparoscopic cystectomy for endometriomas. Fertil Steril 2006, 85:1730-1735.
• [13]Matalliotakis IM, Cakmak H, Mahutte N, Fragouli Y, Arici A, Sakkas D: Women with advanced-stage endometriosis and previous surgery respond less well to gonadotropin stimulation, but have similar IVF implantation and delivery rates compared with women with tubal factor infertility. Fertil Steril 2007, 88:1568-1572.
• [14]Al-Azemi M, Bernal AL, Steele J, Gramsbergen I, Barlow D, Kennedy S: Ovarian response to repeated controlled stimulation in in-vitro fertilization cycles in patients with ovarian endometriosis. Hum Reprod 2000, 15:72-75.
• [15]Almog B, Shehata F, Sheizaf B, Tan SL, Tulandi T: Effects of ovarian endometrioma on the number of oocytes retrieved for in vitro fertilization. Fertil Steril 2011, 95:525-527.
• [16]Benaglia L, Pasin R, Somigliana E, Vercellini P, Ragni G, Fedele L: Unoperated ovarian endometriomas and responsiveness to hyperstimulation. Hum Reprod 2011, 26:1356-1361.
• [17]Society for Assisted Reproductive Technology: National data summary. [http://www.sartcorsonline.com/rptCSR_PublicMultYear.aspx?ClinicPKID=0 webcite]
• [18]American Society for Reproductive Medicine: Revised American Society for Reproductive Medicine classification of endometriosis: 1996. Fertil Steril 1997, 67:817-821.
• [19]Practice Committee of the American Society for Reproductive Medicine: Testing and interpreting measures of ovarian reserve: a committee opinion. Fertil Steril 2012, 98:1407-1415.
• [20]Nelson SM: Biomarkers of ovarian response: current and future applications. Fertil Steril 2013, 99:963-969.
• [21]Shah DK, Mejia RB, Lebovic D: Effect of surgery for endometrioma on ovarian function. J Minim Invasive Gynecol 2014, 21:203-209.
• [22]Geber S, Ferreira DP, Spyer Prates LF, Sales L, Sampaio M: Effects of previous ovarian surgery for endometriosis on the outcome of assisted reproduction treatment. Reprod Biomed Online 2002, 5:162-166.
• [23]Ho HY, Lee RK, Hwu YM, Lin MH, Su JT, Tsai YC: Poor response of ovaries with endometrioma previously treated with cystectomy to controlled ovarian hyperstimulation. J Assist Reprod Genet 2002, 19:507-511.
• [24]Raffi F, Metwally M, Amer S: The impact of excision of ovarian endometrioma on ovarian reserve: a systematic review and meta-analysis. J Clin Endocrinol Metab 2012, 97:3146-3154.
• [25]Somigliana E, Berlanda N, Benaglia L, Vigano’ P, Vercellini P, Fedele L: Surgical excision of endometriomas and ovarian reserve: a systematic review on serum antiMu¨llerian hormone level modifications. Fertil Steril 2012, 98:1531-1538.
• [26]Bongioanni F, Revelli A, Gennarelli G, Guidetti D, Delle Piane LD, Holte J: Ovarian endometriomas and IVF: a retrospective case–control study. Reprod Biol Endocrinol 2011, 17:9-81.
• [27]Hachisuga T, Kawarabayashi T: Histopathological analysis of laparoscopically treated ovarian endometriotic cysts with special reference to loss of follicles. Hum Reprod 2002, 17:432-435.
• [28]Muzii L, Bianchi A, Bellati F, Cristi E, Pernice M, Zullo MA, Angioli R, Panici PB: Histologic analysis of endometriomas: what the surgeon needs to know. Fertil Steril 2007, 87:362-366.
• [29]Kumbak B, Kahraman S, Karlikaya G, Lacin S, Guney A: In vitro fertilization in normoresponder patients with endometriomas comparison with basal simple ovarian cysts. Gynecol Obstet Invest 2008, 65:212-216.
• [30]Canis M, Pouly JL, Tamburro S, Mage G, Wattiez A, Bruhat MA: Ovarian response during IVF-embryo transfer cycles after laparoscopic cysts of >3 cm in diameter. Hum Reprod 2001, 16:2583-2586.
• [31]Donnez J, Wyns C, Nisolle M: Does ovarian surgery for endometriomas impair the ovarian response to gonadotropin? Fertil Steril 2001, 76:662-665.
• [32]Lemos NA, Arbo E, Scalco R, Weiler E, Rosa V, Cunha-Filho JS: Decreased anti-Mullerian hormone and altered ovarian follicular cohort in infertile patients with mild/minimal endometriosis. Fertil Steril 2008, 89:1064-1068.
• [33]Barri PN, Coroleu B, Tur R, Barri-Soldevila PN, Rodríguez I: Endometriosis-associated infertility surgery and IVF a comprehensive therapeutic approach. Reprod Biomed Online 2010, 21:179-185.
• [34]Muzii L, Di Tucci C, Di Feliciantonio M, Marchetti C, Perniola G, Panici PB: The effect of surgery for endometrioma on ovarian reserve evaluated by antral follicle count: a systematic review and meta-analysis. Hum Reprod 2014, 29:2190-2198.
• [35]Muzii L, Miller CE: The singer, not the song. J Minim Invasive Gynecol 2011, 18:666-667.
• [36]Kuivasaari P, Hippelainen M, Anttila M, Heinonen S: Effect of endometriosis on IVF/ICSI outcome: stage III/IV endometriosis worsens cumulative pregnancy and live-born rates. Hum Reprod 2005, 20:3130-3135.
• [37]Al-Fadhli R, Kelly SM, Tulandi T, Tanr SL: Effects of different stages of endometriosis on the outcome of in vitro fertilization. J Obstet Gynaecol Can 2006, 28:888-891.
• [38]Oehninger S, Acosta AA, Kreiner D, Muasher SJ, Jones HW Jr, Rosenwaks Z: In vitro fertilization and embryo transfer (IVF/ET): an established and successful therapy for endometriosis. J In Vitro Fert Embryo Transf 1988, 5:249-256.
• [39]Coccia ME, Rizzello F, Mariani G, Bulletti C, Palagiano A, Scarselli G: Impact of endometriosis on in vitro fertilization and embryo transfer cycles in young women: a stage-dependent interference. Acta Obstet Gynecol Scand 2011, 90:1232-1238.
• [40]Dmowski WP, Rana N, Michalowska J, Friberg J, Papierniak C, el-Roeiy A: The effect of endometriosis, its stage and activity, and of autoantibodies on in vitro fertilization and embryo transfer success rates. Fertil Steril 1995, 63:555-562.
• [41]Opoien HK, Fedorcsak P, Omland AK, Abyholm T, Bjercke S, Ertzeid G, Oldereid N, Mellembakken JR, Tanbo T: In vitro fertilization is a successful treatment in endometriosis-associated infertility. Fertil Steril 2012, 97:912-918.
• [42]Tsoumpou I, Kyrgiou M, Gelbaya TA, Nardo LG: The effect of surgical treatment for endometrioma on in vitro fertilization outcomes: a systematic review and meta-analysis. Fertil Steril 2009, 92:75-87.
• [43]Gupta S, Agarwal A, Agarwal R, Loret de Mola JR: Impact of ovarian endometrioma on assisted reproduction outcomes. Reprod Biomed Online 2006, 13:349-360.
• [44]Surrey ES, Silverberg KM, Surrey MW, Schoolcraft WB: Effect of prolonged gonadotropin-releasing hormone agonist therapy on the outcome of in vitro fertilization-embryo transfer in patients with endometriosis. Fertil Steril 2002, 78:699-704.
• [45]de Ziegler D, Gayet V, Aubriot FX, Fauque P, Streuli I, Wolf JP, de Mouzon J, Chapron C: Use of oral contraceptives in women with endometriosis before assisted reproduction treatment improves outcomes. Fertil Steril 2010, 94:2796-2979.
• [46]Saito H, Seino T, Kaneko T, Nakahara K, Toya M, Kurachi H: Endometriosis and oocyte quality. Gynecol Obstet Invest 2002, 53(Suppl 1):46-51.